Oncology

Multiple Myeloma

Advertisement

Conference Reporter® in Multiple Myeloma to Cover Key Topics Being Presented at the 2026 ASH Annual Meeting

conference reporter by Ajai Chari, MD; Saad Z. Usmani, MBBS, MD, MBA, FACP, FRCP, FASCO
Overview

Conference Reporter delivers health care providers with insights from key thought leaders on exciting news presented at major medical conferences, in a concise and timely format. Conference Reporter will feature community-selected experts and topics in Multiple Myeloma presented at the 2026 ASH Annual Meeting.


VIEW THE TOPICS:

 

  • Factors Contributing to Life Expectancy in Multiple Myeloma
  • Novel Therapeutic Strategies in Multiple Myeloma
  • Patient Monitoring During Treatment in Multiple Myeloma
  • Role of CAR T-Cell Immunotherapy in Multiple Myeloma

 

This information is brought to you by Engage Health Media and is not sponsored, endorsed, or accredited by the American Society of Hematology.

 

68th ASH Annual Meeting

December 12 – December 15, 2026

Ernest N. Morial Convention Center

New Orleans, LA

Registration Link

Ajai Chari, MD

Professor of Clinical Medicine
Director, Multiple Myeloma Program
UCSF Helen Diller Family Comprehensive Cancer Center
University of California, San Francisco
San Francisco, CA

Saad Z. Usmani, MBBS, MD, MBA, FACP, FRCP, FASCO

Chief, Myeloma Service
Member, Myeloma, Cellular Therapy, and Adult BMT Services
Memorial Sloan Kettering Cancer Center
Professor, Clinical Medicine
Weill Cornell Medical College, Cornell University
New York, NY

Advertisement